What Is Complement C4? Normal vs Optimal Range Explained

Laboratory reference ranges for Complement C4 span 10-40 mg/dL, capturing 95% of the general population. The optimal range narrows to 15-35 mg/dL because values at the extremes carry distinct clinical risks that standard lab flags miss entirely. According to 35 causal genes identified in the CTD database, genetic copy-number variation at the C4 locus on chromosome 6 directly determines baseline production capacity. Individuals with only two C4 gene copies can sit at 10-14 mg/dL for their entire lives without symptoms, yet that same level in someone who previously measured 25 mg/dL signals active complement consumption requiring clinical investigation. Tracking personal trends within the 15-35 mg/dL optimal window catches downward shifts months before clinical symptoms emerge, making serial C4 monitoring especially valuable for autoimmune surveillance in at-risk populations.

Low C4 with normal C3 points specifically to classical complement pathway activation, a pattern seen in active systemic lupus erythematosus, hereditary angioedema, and cryoglobulinemia. In a cohort of 667 lupus patients, hypocomplementemia occurred in 48% during active flares, with C4 depression preceding C3 drops by days to weeks because immune complexes consume C4 first in the classical cascade. Hereditary angioedema involves a fundamentally different mechanism: deficiency or dysfunction of C1-inhibitor leads to unregulated C4 cleavage, producing persistently low C4 between and during attacks even when the patient feels well. Distinguishing these causes requires pairing C4 with C3, CH50, and C1-inhibitor functional assays to map exactly where the pathway is disrupted. A C4 value below 15 mg/dL that was previously within optimal range warrants prompt clinical evaluation to identify the driving process before overt symptoms intensify.

Values above 35 mg/dL, while less clinically urgent than low readings, can reflect acute-phase inflammatory responses that deserve attention. C4 is synthesized primarily in the liver and rises during systemic infections, tissue injury, and chronic inflammatory states alongside other acute-phase proteins like CRP and fibrinogen. Persistently elevated C4 above 35 mg/dL in the absence of acute illness may warrant investigation for smoldering inflammation, hepatic overproduction, or underlying malignancy. Monitoring C4 alongside hs-CRP helps distinguish complement-driven immune activation from broader systemic inflammatory states, because CRP rises in both scenarios while C4 elevation is more specific to hepatic acute-phase response. Maintaining C4 within the 15-35 mg/dL optimal corridor, confirmed by at least two measurements taken four or more weeks apart, provides the strongest personalized baseline for detecting future autoimmune or inflammatory shifts early enough to intervene.